Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.
We need your mantras for a new project! Share with us.
We are aware of and actively working on an issue where the first page/opening posts of threads with more than one page are not able to be accessed. We hope to have this resolved soon. Thank you for your patience!
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer
moderators
Posts: 10,281
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer
Dec 17, 2023
More than eight years of follow-up from the KATHERINE trial showed the continued survival benefits of Kadcyla over Herceptin for HER2-positive breast cancer with a high risk of recurrence. Read more…
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your profile.